KLRS · Company research
Kalaris Therapeutics, Inc. Common Stock (KLRS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics (KLRS) Slips 4.87% to $2.25, Drifting Back Toward Support at $2.14 - Arms Index - https://www.siam.in/ | Kalaris Therapeutics (KLRS) Slips 4.87% to $2.25, Drifting Back Toward Support at $2.14 - Arms Index https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 12, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics (KLRS) Stock Analysis Report | Financials & Insights - Benzinga France | Kalaris Therapeutics (KLRS) Stock Analysis Report | Financials & Insights Benzinga France | View source ↗ | Benzinga France | Sep 6, 2026 | neutral | 0 | 0.6 |
| Kalaris (KLRS): Posts a 0.73% Gain to $4.15 on the Day; Range Check: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Force Index - www.dars.gov.et | Kalaris (KLRS): Posts a 0.73% Gain to $4.15 on the Day; Range Check: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Force Index www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 21, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics, Inc. (NASDAQ: KLRS) Share Price, KLRS Stock News, KLRS Share Price & Updates - kalkine.ca | Kalaris Therapeutics, Inc. (NASDAQ: KLRS) Share Price, KLRS Stock News, KLRS Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Aug 11, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics stock falls despite naming new CFO - Investing.com | Kalaris Therapeutics stock falls despite naming new CFO Investing.com | View source ↗ | Investing.com | Jul 20, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics Slides Nearly 5% as Support Levels Come into Focus - Breakout Stock Alerts - dars.gov.et | Kalaris Therapeutics Slides Nearly 5% as Support Levels Come into Focus - Breakout Stock Alerts dars.gov.et | View source ↗ | dars.gov.et | Jul 19, 2026 | neutral | 0 | 0.6 |
| KLRS Stock Dips As Traders React To Volatile Intraday Spike - StocksToTrade | KLRS Stock Dips As Traders React To Volatile Intraday Spike StocksToTrade | View source ↗ | StocksToTrade | Jul 17, 2026 | neutral | 0 | 0.6 |
| KLRS Stock Pops As Kalaris Maps Out TH103 Catalysts - StocksToTrade | KLRS Stock Pops As Kalaris Maps Out TH103 Catalysts StocksToTrade | View source ↗ | StocksToTrade | Jul 17, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics Reports Positive Expanded Phase 1a Data for TH103 in Neovascular AMD | KLRS Stock News - Quiver Quantitative | Kalaris Therapeutics Reports Positive Expanded Phase 1a Data for TH103 in Neovascular AMD | KLRS Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 17, 2026 | neutral | 0 | 0.6 |
| KLRS Stock Dips After Intraday Spike At Key Levels - timothysykes.com | KLRS Stock Dips After Intraday Spike At Key Levels timothysykes.com | View source ↗ | timothysykes.com | Jul 17, 2026 | neutral | 0 | 0.6 |
| KLRS Stock Dips As Traders Weigh Cash Burn And Volatility - www.timothysykes.com | KLRS Stock Dips As Traders Weigh Cash Burn And Volatility www.timothysykes.com | View source ↗ | www.timothysykes.com | Jul 17, 2026 | neutral | 0 | 0.6 |
| KLRS Stock Dips As Traders Digest Heavy Intraday Reversal - StocksToTrade | KLRS Stock Dips As Traders Digest Heavy Intraday Reversal StocksToTrade | View source ↗ | StocksToTrade | Jul 17, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics (KLRS) Appoints Laurie Keating to Board - Yahoo Finance | Kalaris Therapeutics (KLRS) Appoints Laurie Keating to Board Yahoo Finance | View source ↗ | Yahoo Finance | Jul 14, 2026 | neutral | 0 | 0.6 |
| Kaskela Law LLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. Shareholders and Encourages Investors With Losses to Contact The Firm - KLRS - ACCESS Newswire | Kaskela Law LLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. Shareholders and Encourages Investors With Losses to Contact The Firm - KLRS ACCESS Newswire | View source ↗ | ACCESS Newswire | Jun 4, 2026 | neutral | 0 | 0.6 |
| Kalaris Therapeutics: Phase 1a Data De-Risks The Path To 2026 Catalysts (KLRS) - Seeking Alpha | Kalaris Therapeutics: Phase 1a Data De-Risks The Path To 2026 Catalysts (KLRS) Seeking Alpha | View source ↗ | Seeking Alpha | Dec 19, 2025 | neutral | 0 | 0.6 |
| Kalaris Therapeutics: KLRS Stock Price Quote & News - Robinhood | Kalaris Therapeutics: KLRS Stock Price Quote & News Robinhood | View source ↗ | Robinhood | Oct 10, 2025 | neutral | 0 | 0.6 |
| Kalaris Therapeutics (Nasdaq:KLRS) - Stock Analysis - Simply Wall Street | Kalaris Therapeutics (Nasdaq:KLRS) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Mar 24, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 20, 2025 | neutral | 0 | 0.6 |
| KLRS Stock Price and Chart — NASDAQ:KLRS - TradingView | KLRS Stock Price and Chart — NASDAQ:KLRS TradingView | View source ↗ | TradingView | Mar 19, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.